Crucell and Scripps find antibody for universal flu vax

Researchers at Crucell and the Scripps Research Institute have discovered a new antibody that could lead to a universal flu vaccine. According to animal test results, the antibody, CR6261, neutralized multiple flu strains, including H3N2, which killed 1 million people in Asia during the late 1960s. And researchers have found CR8020 is a complementary antibody, which fights the flu strains not affected by CR6261. Release

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.